News
Mayo Clinic research and research education news
October 14, 2019
BEAUTY Update: Progress in breast cancer research
By Advancing the Science contributor 
By Barbara J. Toman Chemotherapy is a standard breast cancer treatment, used for aggressive biology breast cancer to shrink tumors in the breast and lymph nodes before surgery, assess response and destroy any undetected cancer cells elsewhere in the patient. But some breast tumors don’t respond well to chemotherapy, putting patients at high risk of […]
Tags: breast cancer, cancer, Center for Individualized Medicine, chemotherapy, clinical trials, genetics, genomics, individualized medicine, Judy Boughey, Liewei Wang, Matthew Goetz, Mayo Clinic Cancer Center
October 7, 2019
An Artificial Intelligence Tool to Improve Pancreatic Cancer Outcomes
By Advancing the Science contributor
Article by Barbara Toman Only 9% of people with pancreatic cancer live for five years after diagnosis. “That is an abysmally low number, probably the worst in human cancers,” says Michael Wallace, M.D., a digestive disease specialist at the Mayo Clinic campus in Florida. “We want to get that rate substantially higher.” Artificial intelligence is […]
Tags: artificial intelligence, cancer, cancer prevention, cancer screening, Center for Individualized Medicine, Center for the Science of Health Care Delivery, gastroenterology, genetic counseling, genetic testing, imaging, Michael Wallace, pancreatic cancer
October 4, 2019
Chemo first for better outcomes in bile duct cancer, says new research
Oncology care teams frequently use chemotherapy along with surgery to treat cholangiocarcinoma, or bile duct cancer. However, until now, little evidence existed regarding if and when receiving chemotherapy was likely to have the best effect. Recently Mayo Clinic researchers found that patients who received chemotherapy before surgery to remove their bile duct cancer were more […]
Tags: Amit Mahipal, bile ducts, cancer, Center for the Science of Health Care Delivery, chemotherapy, cholangiocarcinoma, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center, oncology, rare disease, Siddhartha Yadav
October 2, 2019
Research News Roundup–September 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research-related news releases from Mayo Clinic in the past month. It also connects readers to associated resources. Read on for more information from Mayo Clinic Research. Medications underused in treating opioid addiction, Mayo Clinic expert says Though research shows that medication-assisted treatment can help […]
Tags: aging, artificial intelligence, ASTRO, basic science, brain tumor, cancer, cardiology, Center for the Science of Health Care Delivery, chemotherapy, clinical trials, collaboration, coronary bypass
September 30, 2019
People with kidney disease should be cautious with supplements, Mayo researchers say
More than one-third of the 15.7 million Americans with moderate or advanced chronic kidney disease use dietary or herbal supplements, reports new research from Mayo Clinic. Many Americans decide to take supplements on their own, not because of a doctor’s recommendation, the researchers found, most often with the goal of improving their health. However, some […]
Tags: Center for the Science of Health Care Delivery, integrative medicine, kidney disease, Rozalina McCoy, Shaheen Kurani
September 27, 2019
Read the Latest Research News from Mayo Clinic Cancer Center
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. The September 2019 issue features: Director’s message: Recognition for a job well doneAfter a rigorous review, NCI has renewed Mayo Clinic Cancer Center’s […]
Tags: Barrett's esophagus, breast cancer, chemotherapy, Donald Northfelt, Forefront, Mayo Clinic Cancer Center, myeloma, National Cancer Institute, pancreatic cancer
September 20, 2019
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs
September 16, 2019
Research breathes new air into donor lungs
By Advancing the Science contributor
By Sara Nick Four hundred: That’s the number of U.S. patients who die each year awaiting a lung transplant, or are removed from the wait list when they become too ill. Now, cutting-edge research underway on Mayo Clinic’s Florida campus aims to save as many of those lives as possible. “We’re hoping to wipe out […]
Tags: Abba Zubair, Center for Regenerative Medicine, David Erasmus, ex vivo lung perfusion, Jorge Mallea, lung transplant, pulmonology, regenerative medicine, stem cells, Transplant Center
September 11, 2019
Targeting therapy to each patient’s unique cancer
By Advancing the Science contributor
Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center, will speak on Decision Support for Precision […]
Tags: Alan Bryce, cancer, Center for Individualized Medicine, clinical trials, DNA, genomics, hematology, Mayo Clinic Cancer Center, oncology, personalized medicine
September 9, 2019
Mayo Clinic Cancer Center Renews National Cancer Institute Research Funding
Mayo Clinic Cancer Center has once again successfully renewed its National Cancer Institute (NCI) Cancer Center Support Grant. The grant award provides roughly $28.7 million in funding over five years through 2024, which will mark Mayo Clinic’s 49th year of NCI funding. Mayo Clinic Cancer Center’s NCI designation as a comprehensive cancer center was also […]
Tags: cancer, Mayo Clinic Cancer Center, National Cancer Institute, research